Real-World Utilisation and Bleed Rates in Patients with Haemophilia B Who Switched to Recombinant Factor IX Fusion Protein (rIX-FP): A Retrospective International Analysis
posted on 2020-04-08, 08:16authored byCedric Hermans, Renato Marino, Catherine Lambert, Sarah Mangles, Patrick Sommerer, Vincent Rives, Geraldine Maro, Giuseppe Malcangi
The above summary slide represents the opinions of the authors. For a full list of
declarations, including funding and author disclosure statements, please see
the full text online (see “read the peer-reviewed publication” opposite).